近日,诺和诺德拟向一家总部位于新加坡的Biotech企业KBP Biosciences(下称KBP)寻求索赔的消息,引发行业不小关注。KBP Biosciences官网显示,该公司在济南、上海均有办事处。公开资料显示,KBP中文名字是亨利医药,公司也有华人背景,是山东人黄振华在2011年所建,黄振华是沈阳药科大学的博士。新加坡国际商事法院官网显示,2月14日,法官批准了诺和诺德对KBP的资产冻结...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.